{"id":33426,"date":"2023-07-19T10:01:20","date_gmt":"2023-07-19T08:01:20","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/?p=33426"},"modified":"2023-07-17T13:46:19","modified_gmt":"2023-07-17T11:46:19","slug":"hydrokortison-bei-schwerer-ambulant-erworbener-pneumonie-ohne-schock-doch-eine-therapieoption","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2023\/hydrokortison-bei-schwerer-ambulant-erworbener-pneumonie-ohne-schock-doch-eine-therapieoption","title":{"rendered":"Hydrokortison bei schwerer ambulant erworbener Pneumonie ohne Schock: doch eine Therapieoption?[CME]"},"content":{"rendered":"<p>Die schwere ambulant erworbene Pneumonie (\u201esevere community-aquired pneumonia\u201c = sCAP) ist h\u00e4ufig mit einer Behandlung auf der Intensivstation verbunden wegen invasiver Beatmung, septischem Schock und\/oder akutem Atemnot-Syndrom (ARDS). Trotz ad\u00e4quater antibiotischer Therapie sterben selbst in L\u00e4ndern mit hohem Bruttosozialprodukt etwa 12% dieser Patienten (), bei Beatmung sogar bis zu 30% (). F\u00fcr die hohe Sterblichkeit [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Die schwere ambulant erworbene Pneumonie (\u201esevere community-aquired pneumonia\u201c = sCAP) ist h\u00e4ufig mit einer Behandlung auf der Intensivstation verbunden wegen invasiver Beatmung, septischem Schock und\/oder akutem Atemnot-Syndrom (ARDS). Trotz ad\u00e4quater antibiotischer Therapie sterben selbst in L\u00e4ndern mit hohem Bruttosozialprodukt etwa 12% dieser Patienten (), bei Beatmung sogar bis zu 30% (). F\u00fcr die hohe Sterblichkeit [&hellip;]<\/p>\n","protected":false},"author":9020,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[5868,5867,246,247,3382,244,3245,5869,5870],"class_list":["post-33426","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-cape-cod-studie","tag-escape-studie","tag-glukokortikoide","tag-glukokortikosteroide","tag-hydrokortison","tag-kortikosteroide","tag-pneumonie","tag-port-studie","tag-santeon-cap-studie"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/33426","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/9020"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=33426"}],"version-history":[{"count":1,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/33426\/revisions"}],"predecessor-version":[{"id":33427,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/33426\/revisions\/33427"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=33426"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=33426"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=33426"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}